Amdocs Weighted Average Shares Trend from 2010 to 2022

DOX
 Stock
  

USD 84.45  1.14  1.37%   

Amdocs Weighted Average Shares yearly trend continues to be fairly stable with very little volatility. Weighted Average Shares is likely to outpace its year average in 2022. During the period from 2010 to 2022, Amdocs Weighted Average Shares regression line of anual values had slope of(4,576,069) and arithmetic mean of  148,052,209. Amdocs Interest Expense is fairly stable at the moment as compared to the past year. Amdocs reported Interest Expense of 12.42 Million in 2021. Weighted Average Shares is likely to rise to about 126.6 M in 2022, whereas Direct Expenses is likely to drop slightly above 2.3 B in 2022.
  
Refresh
Check Amdocs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amdocs main balance sheet or income statement drivers, such as Direct Expenses of 2.3 B, Consolidated Income of 673.8 M or Cost of Revenue of 3.1 B, as well as many exotic indicators such as Interest Coverage of 42.95, Long Term Debt to Equity of 0.16 or Calculated Tax Rate of 13.17. Amdocs financial statements analysis is a perfect complement when working with Amdocs Valuation or Volatility modules. It can also supplement various Amdocs Technical models. Continue to the analysis of Amdocs Correlation against competitors.

Amdocs Quarterly Weighted Average Shares

124.87 Million

Share

Amdocs Weighted Average Shares Breakdown

Showing smoothed Weighted Average Shares of Amdocs Limited with missing and latest data points interpolated. The weighted average number of shares or units issued and outstanding that are used by the company to calculate [EPS]; determined based on the timing of issuance of shares or units in the period.Amdocs' Weighted Average Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amdocs' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 124.62 M10 Years Trend
Decreasing
Slightly volatile
 Weighted Average Shares 
Share
      Timeline 

Amdocs Weighted Average Shares Regression Statistics

Arithmetic Mean 148,052,209
Geometric Mean 147,013,052
Coefficient Of Variation 12.39
Mean Deviation 14,364,811
Median 147,134,228
Standard Deviation 18,340,816
Range 66,830,877
R-Value(0.97)
R-Squared 0.94
Significance 0.00000003
Slope(4,576,069)

Amdocs Weighted Average Shares History

2012161.3 M
2013159 M
2014156.7 M
2015151.2 M
2016147.1 M
2017144.4 M
2018140.2 M
2019134.8 M
2020131.5 M
2021118.4 M
2022126.6 M

Other Fundumenentals of Amdocs Limited

Amdocs Weighted Average Shares component correlations

About Amdocs Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Amdocs income statement, its balance sheet, and the statement of cash flows. Amdocs investors use historical funamental indicators, such as Amdocs's Weighted Average Shares, to determine how well the company is positioned to perform in the future. Although Amdocs investors may use each financial statement separately, they are all related. The changes in Amdocs's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Amdocs's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Amdocs Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Amdocs. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Weighted Average Shares118.4 M126.6 M
Weighted Average Shares Diluted145.2 M148.1 M
Average Assets7.6 B7.1 B
Average Equity4.2 B4.2 B
Invested Capital Average2.6 B2.8 B
Amdocs Limited, through its subsidiaries, provides software and services worldwide. The company designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. It provides CES21, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services the Commerce and Care suite for order capture, handling, and customer engagement the Monetization suite for charging, billing, policy, and revenue management Intelligent Networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys MarketONE, a cloud-native business ecosystem Digital Brands Suite, a pre-integrated digital business suite for digital telecom brands and small-scale service providers and eSIM Cloud for service providers. It also offers AI-powered, cloud-native, and home operating systems data intelligence solutions and applications media services for media publishers, TV networks, and video streaming and service providers end-to-end application development and maintenance services and ongoing services. In addition, the company provides a line of services designed for various stages of a service providers lifecycle includes design, delivery, quality engineering, operations, systems integration, mobile network services, consulting, and content services managed services comprising application development, modernization and maintenance, IT and infrastructure services, testing and professional services that are designed to assist customers in the selection, implementation, operation, management, and maintenance of IT systems. It serves to the communications, cable and satellite, entertainment, and media industry service providers, as well as mobile virtual network operators and directory publishers. Amdocs Limited was founded in 1988 and is headquartered in Chesterfield, Missouri.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Amdocs without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Idea Breakdown Now

   

Idea Breakdown

Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
All  Next Launch Module

Pair Trading with Amdocs

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.

Amdocs Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs Limited to buy it.
The correlation of Amdocs is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to the analysis of Amdocs Correlation against competitors. Note that the Amdocs Limited information on this page should be used as a complementary analysis to other Amdocs' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for Amdocs Stock analysis

When running Amdocs Limited price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
0.41
Market Capitalization
10.4 B
Quarterly Revenue Growth YOY
0.092
Return On Assets
0.0601
Return On Equity
0.16
The market value of Amdocs Limited is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine Amdocs value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.